A strain of Escherichia coli harboring the drug resistance plasmid RP1 was treated with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine, and mutants were isolated in which ampicillin resistance had been lost due to an amber mutation in the plasmid. One of these mutants was again treated, and a strain was isolated in which tetracycline resistance was also lost due to an amber mutation in the plasmid. The plasmid containing amber mutations in the genes amp and tet was named pLM2. This plasmid could be transferred to strains of Pseudomonas aeruginosa, P. phaseolicola, and P. pseudoalcaligenes. Mutants resistant to ampicillin and tetracycline could not be obtained from P. phaseolicola carrying pLM2. However, strains ofE. coli, P. aeruginosa, and P. pseudoalcaligenes carrying the plasmid did produce mutants simultaneously resistant to both antibiotics. All of the mutants of E. coli had developed nonsense suppressors since they became phenotypically lac+, although harboring a lac amber mutation, and formed plaques with amber mutants of phages PRRI and PRD1 that attack organisms carrying RP1. Approximately 20% of the resistant mutants of P. aeruginosa and P. pseudoalcaligenes were sensitive to the amber mutant of PRD1. These mutants were of variable stability and grew somewhat more slowly than their parent strains. One of the suppressor mutants of P. pseudoalcaligenes, designated ERA(pLM2)S4, was used for the isolation of nonsense mutants of bacteriophage 46, a virus having a segmented genome of double-stranded ribonucleic acid and an envelope of lipids and proteins.
Genetic suppression of nonsense mutations was first described in Escherichia coli (4, 6) . Nonsense suppressors have been subsequently demonstrated in other microorganisms such as Bacillus subtilis (12) and Saccharomyces cerevisiae (6) . These mutations have been of great value in the elucidation of viral structure and morphogenesis since they allow the isolation of nonsense mutants of bacteriophages, which can be analyzed in a manner that can identify the product of the gene in which each nonsense mutation occurs. Using these mutants that produce only fragments of particular proteins, it has been possible to work out morphogenetic pathways in phage development and to determine the roles of particular proteins in phage development (10, 19, 20, 24) . We have been studying the development of bacteriophage 06, which is of special interest because it has a genome composed of three pieces of doublestranded ribonucleic acid (RNA) and an envelope structure composed of an icosahedral core with a lipid-containing, membrane-like outer layer (16, 17, 22) . To facilitate this study, we endeavored to isolate suppressor mutants of Pseudomonas phaseolicola, the natural host of this bacteriophage. We found that such mutants could not be obtained in this strain, but we did succeed in isolating a new host for 06, called P. pseudoalcaligenes ERA. Suppressors were obtained in this strain, as well as in P. aeruginosa, using plasmid pLM2, which was prepared in this study.
MATERIALS AND METHODS
Bacterial strains. The bacterial strains used are listed in Table 1 . P. phaseolicola HB1OY and bacteriophage 46 were obtained from A. Vidaver (22) . PAT904(RP1), a strain of P. aeruginosa carrying plasmid RP1, was obtained from R. Olsen, who also supplied bacteriophages PRR1 and PRD1 (13, 14) that form plaques on many different species carrying RP1. E. coli CA274 carrying amber mutations in lac and trp was obtained from J. D. Smith (15) . P. aeruginosa strain PA01 was obtained from A. Emerick. E. coli strains K37 and K38 were obtained from N. Zinder. K37 contains a suppressor, supD, (3, 7, 24) , whereas K38 has no suppressor.
Media. LC broth and agar was used for most experiments. This medium contains 10 g oftryptone, 5 g of yeast extract, and 5 g of NaCl per liter, pH 7.0. Bottom agar contained 1.5% agar and top agar was 2.5 ml of LC with 0.6% agar. Synthetic medium was M8 (17) , with glucose or lactate as the carbon source (3, 7, 24) and amino acids as required. Ampicillin, kanamycin, and tetracycline resistances were assayed at 400, 50, and 25 ,ug/ml, respectively, for E. coli, P. phaseolicola, and P. pseudoalcaligenes. Concentrations of 2 mg/ml, 400 lAg/ml, and 200 Ag/ml, respectively, were used for P. aeruginosa. Ampicillin and kanamycin were generous gifts of Bristol Laboratories. Tetracycline was purchased from Sigma Chemical Co. Mutagenesis of bacteria. Overnight cultures in LC broth were centrifuged and resuspended in 10 ml of M8 salts (17) and treated with 0.2 ml of ethyl methane sulfonate (EMS) for 40 min, centrifuged again, resuspended in LC broth, washed once more, and then incubated overnight in LC broth. Treatment was at 26 C for P. phaseolicola and at 37 C for all other strains. Mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine (NTG) was as described by Adelberg et al. (1) , using tris(hydroxymethyl)-aminomethane-maleate buffer, pH 6, and 200 ,ug of NTG per ml.
Mutagenesis of bacteriophages. PRR1 was treated with 0.05 M sodium nitrite in LC broth containing 0.25 M acetate, pH 4.4, for 1 h at 25 C (24). Survival was 2 x 10-5. Mutagenized phage was plated on K37(RP1), and 1,000 plaques were picked with toothpicks and stabbed into lawns of K37(RP1) and K38(RP1). Two mutants were isolated that formned plaques on suppressor-containing strains but not on others. They were designated PRR1 sus-1 and sus-2.
PRD1 was mutagenized with 25 pg of NTG per ml while infecting K37(RP1) by the procedure of Studier (19) for T7. The mutagenized phage was plated as described for PRR1, and mutants were designated PRD1 sus-1 and sus-2. The reversion frequency of the amber mutants of PRR1 was approximately 10-3 and for those of PRD1, approximately 10-6, consistent with the RNA and deoxyribonucleic acid respective compositions of the bacteriophages (13, 14) . 46hls was mutagenized by incubating virus for 3 days in tris(hydroxymethyl)aminomethane-maleate buffer, pH 6, (1) containing 1 mg of NTG per ml.
Transfer of RP1. Transfer of plasmids was usually as described by Olsen and Shipley (13) . In many cases transfer was effected by simply cross-streaking overnight cultures of the donor and recipient strains on media containing kanamycin to select for plasmid-containing strains and the proper conditions to select against the donor strain. Transfer was at high frequency (greater than 0.01%), except in the case of transfers to P. phaseolicola. Transfers to this strain could be effected by plating approximately 109 donor and recipient cells per plate. Transfer frequency was about 1 in 109 cells. However, this frequency could be raised about 100-fold by mutagenizing the recipient cells with EMS.
Selection of amber mutations in drug resistance. RP1 was transferred from HB(RP1) to E. coli CA274 su-by selecting for kanamycin resistance at 37 C. CA274(RP1) was mutagenized with NTG, and 2 x 104 cells were plated on GL agar (11) containing kanamycin. These plates were replicated both with and without ampicillin (400 ,ug/ml). Forty ampicillin-sensitive colonies were isolated. Twenty-four were found to be penicillinase negative by a staining test (11) . These were purified and cross-streaked against K37 and K38 on ampicillin-containing plates that lacked tryptophan. One of the isolated mutants transferred ampicillin resistance to K37 but not to K38 and was designated CA274 (pLM1). This strain was again mutagenized, grown overnight, reinoculated into fresh LC broth with 25 ,ug of tetracycline per ml, and grown for 30 min before adding 1,000 U of penicillin G per ml. After several hours, the culture lysed and was centrifuged and washed twice with LC broth and plated on LC agar plates. These plates were replica plated onto plates with and without tetracycline. Of 33 tetracyclinesensitive mutants, 2 transferred resistance to K37 but not to K38. One of these strains was designated CA274(pLM2).
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The plasmid pLM2 is transferable and carries resistance to kanamycin and amber mutations in. the genes for ampicillin and tetracycline resistance. The resistance to ampicillin in suppressor strains containing supD is temperature sensitive above 37 C.
Taxonomic classification of strain ERA. Standard techniques of identification (8, 23) were applied to strain ERA (Table 2) .
RESULTS
General strategy for the preparation of a suppressor strain. The plasmid RP1 can transfer across generic lines in gram-negative bacte- (5, 13) . In particular, it is easily transferred between pseudomonads and E. coli (5, 13) . In addition, two bacteriophages, PRR1 and PRD1, that attack strains carrying RP1 have been isolated (13, 14) . The original plan of this study was to transfer RP1 into P. phaseolicola HB1OY (called HB in this report), obtain many amino acid auxotrophic mutants, among which some would be due to nonsense mutations, isolate revertants of these mutants, and test their capacity as suppressors with amber mutants of phages PRR1 or PRD1.
The transfer of RP1 to HB was accomplished. The frequency of transfer was found to be very low (about 10-s to 10-9) when E. coli CA274(RP1) was the donor and untreated HB was the recipient. However, the frequency of transfer was increased to about 106 after mutagenesis of HB with EMS. The effect of this mutagenesis persisted in that a strain of HB(RP1) could be cured of RP1 by selecting for phage PRD1-resistant mutants, and the cured strain showed a very high frequency of uptake of RP1 on subsequent tests (>10-5).
Auxotrophic mutants of HB(RP1) were isolated as described above, and revertants were isolated and tested by cross-streaking for growth of the amber mutants of phage PRR1. None ofthe revertants grew the amber mutants of the phage. Ultimately, 180 amino acid auxotrophs of HB(RP1) were isolated, and approximately five revertants ofeach were isolated and tested with no success. Twenty double auxotrophic muitants were isolated from each of 15 single auxotrophs, and revertants were isolated from several of these. None was able to grow the amber mutants of PRR1.
The second plan for isolating suppressor mutants involved the preparation of double amber mutants for ampicillin and tetracycline resistance in RP1. Since the plasmid carries the genes for kanamycin, tetracycline, and ampicillin resistances, it should be possible to isolate a mutant plasmid that has amber mutations in the tet and amp genes and use the kanamycin resistance as a selection for transfer to HB. E. coli CA274(RP1) was mutagenized and tested as described above, and the resulting plasmid that conferred ampicillin and tetracycline resistances only on suppressor strains was designated pLM2.
Transfer of pLM2 to HB. The plasmid pLM2 could be transferred from CA274(pLM2) to HB by selecting for kanamycin resistance and tryptophan prototrophy, since the donor required tryptophan and HB did not. Transfer occurred at a frequency of 10-9. The resulting strain HB(pLM2) was mutagenized with either EMS, NTG, or ultraviolet light, grown overnight in (Table 3 ). The EOP of 06hl was 100-fold lower on S4 than on ERA; therefore, an additional mutant of the virus was isolated that has an EOP of 0.6 on S4. This is called 46hls.
Nonsense mutants in 06hls. A preparation of 4A6h1s was mutagenized by treatment with NTG at 1 mg/ml for 3 days at room temperature. The virus was then plated on S4, and plaques were picked with sterile toothpicks and stabbed into fresh plates of S4 and HB. Mutants were obtained with a frequency of 0.5% that grew on S4 and not on HB, HB(RP1), HB(pLM2), ERA, or ERA(pLM2). The analysis of these mutants is the subject of a report in preparation.
Transfer of pLM2 to P. aeruginosa strain PAO1. The transfer of the plasmid to strains of P. aeruginosa is made difficult by their natural high levels of resistance to ampicillin, tetracycline, and kanamycin. The concentration of kanamycin for transfer selection was 400 ,ug/ ml. PAO1(pLM2) was mutagenized with EMS and spread on plates containing 2 mg of ampicillin and 200 ,ug of tetracycline per ml. Mutants resistant to both antibiotics were obtained and tested for the ability to support the growth of PRD1 sus-1. Of 20 mutants tested, 5 supported the amber mutant phage. Three of these mutants were designated PAO1(pLM2) supA, supB, and supC, respectively. The suppressor mutations in P. aeruginosa seem to be more stable than those in strain ERA. Table 3 shows the relative plating characteristics of the various amber phage mutants on the suppressor strains discussed in this report. It should be noted that the amber mutant of PRD1 was able to grow on suppressor strains of E. coli, P. aeruginosa, and P. pseudoalcaligenes. Although the results are not shown, the EOP of PRD1 on E. coli K37 and K38 and on P. pseudoalcaligenes was at least 1,000-fold lower at 25 C than at 37 C. This difference was not seen with P. aeruginosa. On the other hand, although PRR1 plated with a higher EOP at 37 C than at 25 C, the amber mutant PRR1 sus-1 had a higher EOP at 25 C than at 37 C. This mutant did not seem to be suppressed at 25 C by the P. aeruginosa strains that supported the growth of PRD1 sus-1. P. aeruginosa PAO1-(pLM2) susB did seem to suppress PRR1 sus-1 to a slight degree at 37 C. DISCUSSION The primary goal of this project, the isolation of a suppressor host for bacteriophage 06, was accomplished. However, some of the secondary results will be of value in other systems. The plasmid bearing two amber mutants in drug resistance should be of use in the isolation of suppressor mutants in the various genera that can carry RP1. In this report we have demonstrated its utility for E. coli, P. pseudoalcaligenes, and P. aeruginosa. An amber mutation in ampicillin resistance of plasmid Rl has been used in isolating nonsense suppressors on the Enterobacteriaceae (9). Suppressor mutations have not been described previously in pseudomonads, and our system should be of special usefulness in the study of the physiology of the pseudomonads and their bacteriophages. In principle, it should be possible to isolate nonsense suppressor mutations in all species that can carry RP1. Similarly, the amber mutant of PRD1 should facilitate the testing of the suppressor activity in these strains.
The reason for our lack of success in isolating nonsense suppressors in HB is not known. The most likely possibilities are that either there is a paucity of dispensible transfer RNA genes that can form suppressors, with suppressor mutations then being lethal (18) , or suppressors when formed do not express themselves. The latter would be the case if the peptide chain termination system worked so efficiently that the suppressor transfer RNA could not compete with the termination system. Mutants that are, perhaps, of this type have been described by Elseviers and Gorini (2) . In these mutants, suppression is diminished by mutations mapping in the region of ribosomal protein structural genes. Another possibility would be that the amber codon UAG is used in normal termination, as has been found for some phages (21) .
In the case of suppressor mutations in ERA and P. aeruginosa, the instability may be due to the same effects described above. The effect does not seem to be due to the plasmid since the suppressors isolated in E. coli using the same system are stable.
The 
